This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Aug 4;324(5):517.

doi: 10.1001/jama.2020.8648.

Research and Development Costs of New Drugs

Joseph A DiMasi¹

Affiliations

PMID: 32749485
DOI: 10.1001/jama.2020.8648

Comment

Research and Development Costs of New Drugs

Joseph A DiMasi. JAMA. 2020.

. 2020 Aug 4;324(5):517.

doi: 10.1001/jama.2020.8648.

Author

Joseph A DiMasi¹

Affiliation

¹ Tufts Center for the Study of Drug Development, Tufts University, Boston, Massachusetts.

PMID: 32749485
DOI: 10.1001/jama.2020.8648

Erratum in

Error in Data in Study of Estimated Cost of Bringing a Drug to Market.
[No authors listed] [No authors listed] JAMA. 2022 Sep 20;328(11):1111. doi: 10.1001/jama.2022.14733. JAMA. 2022. PMID: 36125490 Free PMC article. No abstract available.

No abstract available

PubMed Disclaimer

Comment in

Research and Development Costs of New Drugs-Reply.
Wouters OJ, McKee M, Luyten J. Wouters OJ, et al. JAMA. 2020 Aug 4;324(5):518. doi: 10.1001/jama.2020.8651. JAMA. 2020. PMID: 32749488 No abstract available.

Comment on

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.
Wouters OJ, McKee M, Luyten J. Wouters OJ, et al. JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166. JAMA. 2020. PMID: 32125404 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems